Standard BioTools Inc. (LAB)
NASDAQ: LAB
· Real-Time Price · USD
1.31
-0.07 (-5.07%)
At close: Sep 24, 2025, 3:59 PM
1.30
-0.76%
After-hours: Sep 24, 2025, 07:40 PM EDT
-5.07% (1D)
| Bid | 1.25 |
| Market Cap | 500.41M |
| Revenue (ttm) | 154.24M |
| Net Income (ttm) | -120.5M |
| EPS (ttm) | -0.37 |
| PE Ratio (ttm) | -3.54 |
| Forward PE | -9.33 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 1.35 |
| Volume | 1,103,680 |
| Avg. Volume (20D) | 1,443,322 |
| Open | 1.39 |
| Previous Close | 1.38 |
| Day's Range | 1.27 - 1.39 |
| 52-Week Range | 0.92 - 2.32 |
| Beta | 1.29 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for LAB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsStandard BioTools Inc. is scheduled to release its earnings on
Oct 29, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+17.14%
Standard BioTools shares are trading higher after ...
Unlock content with
Pro Subscription
4 months ago
-3.77%
LAB stock has given up its prior gain. Standard BioTools shares were trading higher after the company reported better-than-expected Q1 sales results.
